230 related articles for article (PubMed ID: 12231530)
1. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
Okochi O; Hibi K; Uemura T; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2002 Sep; 8(9):2875-8. PubMed ID: 12231530
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.
Nomoto S; Yamashita K; Koshikawa K; Nakao A; Sidransky D
Clin Cancer Res; 2002 Feb; 8(2):481-7. PubMed ID: 11839667
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
[TBL] [Abstract][Full Text] [Related]
4. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
6. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.
Takeuchi H; Fujimoto A; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():50-4. PubMed ID: 15251939
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
Nishikawa M; Nishiguchi S; Shiomi S; Tamori A; Koh N; Takeda T; Kubo S; Hirohashi K; Kinoshita H; Sato E; Inoue M
Cancer Res; 2001 Mar; 61(5):1843-5. PubMed ID: 11280735
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of mitochondrial genome in hepatocellular carcinoma.
Yin PH; Wu CC; Lin JC; Chi CW; Wei YH; Lee HC
Mitochondrion; 2010 Mar; 10(2):174-82. PubMed ID: 20006738
[TBL] [Abstract][Full Text] [Related]
9. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of mitochondrial mutations in colorectal cancer.
Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
[TBL] [Abstract][Full Text] [Related]
11. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.
Pejovic T; Ladner D; Intengan M; Zheng K; Fairchild T; Dillon D; Easley S; Dillon D; Marchetti D; Schwartz P; Lele S; Costa J; Odunsi K
Eur J Cancer; 2004 Nov; 40(16):2519-24. PubMed ID: 15519528
[TBL] [Abstract][Full Text] [Related]
12. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
13. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients.
Jackson PE; Kuang SY; Wang JB; Strickland PT; Muñoz A; Kensler TW; Qian GS; Groopman JD
Carcinogenesis; 2003 Oct; 24(10):1657-63. PubMed ID: 12869416
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer.
Wu CW; Yin PH; Hung WY; Li AF; Li SH; Chi CW; Wei YH; Lee HC
Genes Chromosomes Cancer; 2005 Sep; 44(1):19-28. PubMed ID: 15892105
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer.
Tseng LM; Yin PH; Chi CW; Hsu CY; Wu CW; Lee LM; Wei YH; Lee HC
Genes Chromosomes Cancer; 2006 Jul; 45(7):629-38. PubMed ID: 16568452
[TBL] [Abstract][Full Text] [Related]
16. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas.
Liu VW; Shi HH; Cheung AN; Chiu PM; Leung TW; Nagley P; Wong LC; Ngan HY
Cancer Res; 2001 Aug; 61(16):5998-6001. PubMed ID: 11507041
[TBL] [Abstract][Full Text] [Related]
17. Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer?
Losanoff JE; Zhu W; Qin W; Mannello F; Sauter ER
Breast; 2008 Oct; 17(5):540-2. PubMed ID: 18571924
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
19. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
20. Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer.
Van Trappen PO; Cullup T; Troke R; Swann D; Shepherd JH; Jacobs IJ; Gayther SA; Mein CA
Gynecol Oncol; 2007 Jan; 104(1):129-33. PubMed ID: 16942794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
